Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
The development of effective malaria vaccines remains a global health priority. Currently, the most advanced vaccine, known as RTS,S, has only shown modest efficacy in clinical trials. Thus, the development of more efficacious vaccines by improving the formulation of RTS,S for increased efficacy or...
Main Authors: | Jo-Anne Chan, David Wetzel, Linda Reiling, Kazutoyo Miura, Damien R Drew, Paul R Gilson, David A Anderson, Jack S Richards, Carole A Long, Manfred Suckow, Volker Jenzelewski, Takafumi Tsuboi, Michelle J Boyle, Michael Piontek, James G Beeson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0221733 |
Similar Items
-
Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha.
by: David Wetzel, et al.
Published: (2019-01-01) -
Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice
by: Liriye Kurtovic, et al.
Published: (2021-03-01) -
Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity
by: Cosette G. Schneider, et al.
Published: (2021-01-01) -
Maintaining immunogenicity of blood stage and sexual stage subunit malaria vaccines when formulated in combination.
by: Elizabeth M Parzych, et al.
Published: (2020-01-01) -
Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.
by: Sheetij Dutta, et al.
Published: (2013-01-01)